How Moffitt could play a role in finding a treatment for ovarian cancer

A California biotechnology company has signed an agreement with Moffitt Cancer Center in Tampa to do the research and development work for a potential immunotherapy to treat ovarian cancer. ITUS Corp. (NASDAQ: ITUS), based in San Jose, California, will pay Moffitt about $1.2 million over two years, as part of a cooperative research and development agreement, Amit Kuman, president and CEO of ITUS, said in a conference call Tuesday. Leading the work will be Dr. Jose Conejo Garcia, a M offitt researcher…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news